Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Commentaries

DYRK1A: A Promising Drug Target for Islet Transplant–Based Diabetes Therapies

  1. Bengt-Frederik Belgardt1 and
  2. Eckhard Lammert1,2⇑
  1. 1Institute for Beta Cell Biology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research, and German Center for Diabetes Research (DZD e.V.), Düsseldorf, Germany
  2. 2Institute for Metabolic Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
  1. Corresponding author: Eckhard Lammert, lammert{at}hhu.de.
Diabetes 2016 Jun; 65(6): 1496-1498. https://doi.org/10.2337/dbi16-0013
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 6 1496-1498
DOI 
https://doi.org/10.2337/dbi16-0013
PubMed 
27222397

Published By 
American Diabetes Association
Print ISSN 
0012-1797
Online ISSN 
1939-327X
History 
  • Published in print May 24, 2016.

Copyright & Usage 
© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Author Information

  1. Bengt-Frederik Belgardt1 and
  2. Eckhard Lammert1,2⇑
  1. 1Institute for Beta Cell Biology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research, and German Center for Diabetes Research (DZD e.V.), Düsseldorf, Germany
  2. 2Institute for Metabolic Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
  1. Corresponding author: Eckhard Lammert, lammert{at}hhu.de.

Statistics from Altmetric.com

Article usage

Article usage: May 2016 to April 2021

Rendering graph...
AbstractFullPdf
May 20161947875
Jun 201620848109
Jul 2016514435
Aug 2016128139
Sep 2016117233
Oct 201648234
Nov 201685336
Dec 2016115034
Jan 201725239
Feb 201704442
Mar 201723726
Apr 201728821
May 201703415
Jun 201753828
Jul 201703129
Aug 201703216
Sep 201703621
Oct 201704227
Nov 201715524
Dec 201713516
Jan 201805322
Feb 201833912
Mar 201814619
Apr 201814024
May 201826515
Jun 201823019
Jul 201824019
Aug 201803713
Sep 201823215
Oct 201804811
Nov 201806014
Dec 20180369
Jan 20190389
Feb 20191479
Mar 201912929
Apr 20190228
May 201952613
Jun 201912410
Jul 201913715
Aug 201984520
Sep 201914910
Oct 201974210
Nov 201924315
Dec 201904810
Jan 20204288
Feb 202008424
Mar 2020210215
Apr 202024113
May 202025837
Jun 202002013
Jul 20202499
Aug 202021710
Sep 202024314
Oct 202013614
Nov 202045023
Dec 202044217
Jan 202104112
Feb 202123515
Mar 202124313
Apr 20211102

PreviousNext
Back to top
Diabetes: 65 (6)

In this Issue

June 2016, 65(6)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
DYRK1A: A Promising Drug Target for Islet Transplant–Based Diabetes Therapies
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
DYRK1A: A Promising Drug Target for Islet Transplant–Based Diabetes Therapies
Bengt-Frederik Belgardt, Eckhard Lammert
Diabetes Jun 2016, 65 (6) 1496-1498; DOI: 10.2337/dbi16-0013

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

DYRK1A: A Promising Drug Target for Islet Transplant–Based Diabetes Therapies
Bengt-Frederik Belgardt, Eckhard Lammert
Diabetes Jun 2016, 65 (6) 1496-1498; DOI: 10.2337/dbi16-0013
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Adipose Tissue Malfunction Drives Metabolic Dysfunction in Alström Syndrome
  • Staying Connected: Transcriptomics in the Search for Novel Diabetic Kidney Disease Treatments
  • Going in Early: Hypoxia as a Target for Kidney Disease Prevention in Diabetes?
Show more Commentaries

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.